PTEN Reduces BMP9-Induced Osteogenic Differentiation Through Inhibiting Wnt10b in Mesenchymal Stem Cells

Bone morphogenetic protein 9 (BMP9) is one of the most efficacious osteogenic cytokines. PTEN and Wnt10b are both implicated in regulating the osteogenic potential of BMP9, but the potential relationship between them is unknown. In this study, we determined whether PTEN could reduce the expression o...

Full description

Bibliographic Details
Main Authors: Fu-Shu Li, Pei-Pei Li, Ling Li, Yan Deng, Ying Hu, Bai-Cheng He
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2020.608544/full
id doaj-437f2c67472042bcb4bddfb0f1e29294
record_format Article
spelling doaj-437f2c67472042bcb4bddfb0f1e292942021-02-04T05:29:28ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2021-02-01810.3389/fcell.2020.608544608544PTEN Reduces BMP9-Induced Osteogenic Differentiation Through Inhibiting Wnt10b in Mesenchymal Stem CellsFu-Shu Li0Fu-Shu Li1Pei-Pei Li2Pei-Pei Li3Ling Li4Ling Li5Yan Deng6Yan Deng7Ying Hu8Ying Hu9Bai-Cheng He10Bai-Cheng He11Department of Pharmacology, School of Pharmacy, Chongqing Medical University, Chongqing, ChinaKey Laboratory of Biochemistry and Molecular Pharmacology of Chongqing, Chongqing Medical University, Chongqing, ChinaDepartment of Pharmacology, School of Pharmacy, Chongqing Medical University, Chongqing, ChinaKey Laboratory of Biochemistry and Molecular Pharmacology of Chongqing, Chongqing Medical University, Chongqing, ChinaDepartment of Pharmacology, School of Pharmacy, Chongqing Medical University, Chongqing, ChinaKey Laboratory of Biochemistry and Molecular Pharmacology of Chongqing, Chongqing Medical University, Chongqing, ChinaDepartment of Pharmacology, School of Pharmacy, Chongqing Medical University, Chongqing, ChinaKey Laboratory of Biochemistry and Molecular Pharmacology of Chongqing, Chongqing Medical University, Chongqing, ChinaDepartment of Pharmacology, School of Pharmacy, Chongqing Medical University, Chongqing, ChinaKey Laboratory of Biochemistry and Molecular Pharmacology of Chongqing, Chongqing Medical University, Chongqing, ChinaDepartment of Pharmacology, School of Pharmacy, Chongqing Medical University, Chongqing, ChinaKey Laboratory of Biochemistry and Molecular Pharmacology of Chongqing, Chongqing Medical University, Chongqing, ChinaBone morphogenetic protein 9 (BMP9) is one of the most efficacious osteogenic cytokines. PTEN and Wnt10b are both implicated in regulating the osteogenic potential of BMP9, but the potential relationship between them is unknown. In this study, we determined whether PTEN could reduce the expression of Wnt10b during the osteogenic process initialized by BMP9 in mesenchymal stem cells (MSCs) and the possible molecular mechanism. We find that PTEN is inhibited by BMP9 in MSCs, but Wnt10b is increased simultaneously. The BMP9-induced osteogenic markers are reduced by PTEN but increased by silencing PTEN. The effects of knockdown PTEN on elevating BMP9-induced osteogenic markers are almost abolished by knockdown of Wnt10b. On the contrary, the BMP9-increased ALP activities and mineralization are both inhibited by PTEN but almost reversed by the combination of Wnt10b. Bone masses induced by BMP9 are enhanced by knockdown of PTEN, which is reduced by knockdown of Wnt10b. The BMP9-increased Wnt10b is decreased by PTEN but enhanced by knockdown of PTEN. Meanwhile, the BMP9-induced Wnt10b is also reduced by a PI3K-specific inhibitor (Ly294002) or rapamycin, respectively. The BMP9-induced phosphorylation of CREB or Smad1/5/9 is also reduced by PTEN, but enhanced by PTEN knockdown. In addition, p-CREB interacts with p-Smad1/5/9 in MSCs, and p-CREB or p-Smad1/5/9 are both enriched at the promoter region of Wnt10b. Our findings indicate that inhibitory effects of PTEN on BMP9's osteogenic potential may be partially mediated through decreasing the expression of Wnt10b via the disturbance of interaction between CREB and BMP/Smad signaling.https://www.frontiersin.org/articles/10.3389/fcell.2020.608544/fullphosphatase and tensin homolog deleted on chromosome 10WNT10BBMP9osteogenic differentiationmesenchymal stem cell
collection DOAJ
language English
format Article
sources DOAJ
author Fu-Shu Li
Fu-Shu Li
Pei-Pei Li
Pei-Pei Li
Ling Li
Ling Li
Yan Deng
Yan Deng
Ying Hu
Ying Hu
Bai-Cheng He
Bai-Cheng He
spellingShingle Fu-Shu Li
Fu-Shu Li
Pei-Pei Li
Pei-Pei Li
Ling Li
Ling Li
Yan Deng
Yan Deng
Ying Hu
Ying Hu
Bai-Cheng He
Bai-Cheng He
PTEN Reduces BMP9-Induced Osteogenic Differentiation Through Inhibiting Wnt10b in Mesenchymal Stem Cells
Frontiers in Cell and Developmental Biology
phosphatase and tensin homolog deleted on chromosome 10
WNT10B
BMP9
osteogenic differentiation
mesenchymal stem cell
author_facet Fu-Shu Li
Fu-Shu Li
Pei-Pei Li
Pei-Pei Li
Ling Li
Ling Li
Yan Deng
Yan Deng
Ying Hu
Ying Hu
Bai-Cheng He
Bai-Cheng He
author_sort Fu-Shu Li
title PTEN Reduces BMP9-Induced Osteogenic Differentiation Through Inhibiting Wnt10b in Mesenchymal Stem Cells
title_short PTEN Reduces BMP9-Induced Osteogenic Differentiation Through Inhibiting Wnt10b in Mesenchymal Stem Cells
title_full PTEN Reduces BMP9-Induced Osteogenic Differentiation Through Inhibiting Wnt10b in Mesenchymal Stem Cells
title_fullStr PTEN Reduces BMP9-Induced Osteogenic Differentiation Through Inhibiting Wnt10b in Mesenchymal Stem Cells
title_full_unstemmed PTEN Reduces BMP9-Induced Osteogenic Differentiation Through Inhibiting Wnt10b in Mesenchymal Stem Cells
title_sort pten reduces bmp9-induced osteogenic differentiation through inhibiting wnt10b in mesenchymal stem cells
publisher Frontiers Media S.A.
series Frontiers in Cell and Developmental Biology
issn 2296-634X
publishDate 2021-02-01
description Bone morphogenetic protein 9 (BMP9) is one of the most efficacious osteogenic cytokines. PTEN and Wnt10b are both implicated in regulating the osteogenic potential of BMP9, but the potential relationship between them is unknown. In this study, we determined whether PTEN could reduce the expression of Wnt10b during the osteogenic process initialized by BMP9 in mesenchymal stem cells (MSCs) and the possible molecular mechanism. We find that PTEN is inhibited by BMP9 in MSCs, but Wnt10b is increased simultaneously. The BMP9-induced osteogenic markers are reduced by PTEN but increased by silencing PTEN. The effects of knockdown PTEN on elevating BMP9-induced osteogenic markers are almost abolished by knockdown of Wnt10b. On the contrary, the BMP9-increased ALP activities and mineralization are both inhibited by PTEN but almost reversed by the combination of Wnt10b. Bone masses induced by BMP9 are enhanced by knockdown of PTEN, which is reduced by knockdown of Wnt10b. The BMP9-increased Wnt10b is decreased by PTEN but enhanced by knockdown of PTEN. Meanwhile, the BMP9-induced Wnt10b is also reduced by a PI3K-specific inhibitor (Ly294002) or rapamycin, respectively. The BMP9-induced phosphorylation of CREB or Smad1/5/9 is also reduced by PTEN, but enhanced by PTEN knockdown. In addition, p-CREB interacts with p-Smad1/5/9 in MSCs, and p-CREB or p-Smad1/5/9 are both enriched at the promoter region of Wnt10b. Our findings indicate that inhibitory effects of PTEN on BMP9's osteogenic potential may be partially mediated through decreasing the expression of Wnt10b via the disturbance of interaction between CREB and BMP/Smad signaling.
topic phosphatase and tensin homolog deleted on chromosome 10
WNT10B
BMP9
osteogenic differentiation
mesenchymal stem cell
url https://www.frontiersin.org/articles/10.3389/fcell.2020.608544/full
work_keys_str_mv AT fushuli ptenreducesbmp9inducedosteogenicdifferentiationthroughinhibitingwnt10binmesenchymalstemcells
AT fushuli ptenreducesbmp9inducedosteogenicdifferentiationthroughinhibitingwnt10binmesenchymalstemcells
AT peipeili ptenreducesbmp9inducedosteogenicdifferentiationthroughinhibitingwnt10binmesenchymalstemcells
AT peipeili ptenreducesbmp9inducedosteogenicdifferentiationthroughinhibitingwnt10binmesenchymalstemcells
AT lingli ptenreducesbmp9inducedosteogenicdifferentiationthroughinhibitingwnt10binmesenchymalstemcells
AT lingli ptenreducesbmp9inducedosteogenicdifferentiationthroughinhibitingwnt10binmesenchymalstemcells
AT yandeng ptenreducesbmp9inducedosteogenicdifferentiationthroughinhibitingwnt10binmesenchymalstemcells
AT yandeng ptenreducesbmp9inducedosteogenicdifferentiationthroughinhibitingwnt10binmesenchymalstemcells
AT yinghu ptenreducesbmp9inducedosteogenicdifferentiationthroughinhibitingwnt10binmesenchymalstemcells
AT yinghu ptenreducesbmp9inducedosteogenicdifferentiationthroughinhibitingwnt10binmesenchymalstemcells
AT baichenghe ptenreducesbmp9inducedosteogenicdifferentiationthroughinhibitingwnt10binmesenchymalstemcells
AT baichenghe ptenreducesbmp9inducedosteogenicdifferentiationthroughinhibitingwnt10binmesenchymalstemcells
_version_ 1724285456627007488